Provided by Tiger Trade Technology Pte. Ltd.

IO Biotech, Inc.

0.8100
-0.0366-4.32%
Post-market: 0.7938-0.0162-2.00%17:23 EST
Volume:316.83K
Turnover:255.20K
Market Cap:58.28M
PE:-0.61
High:0.8310
Open:0.8300
Low:0.7800
Close:0.8466
52wk High:2.79
52wk Low:0.3234
Shares:71.95M
Float Shares:31.16M
Volume Ratio:0.30
T/O Rate:1.02%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.3356
EPS(LYR):-1.4494
ROE:-240.48%
ROA:-88.58%
PB:63.97
PE(LYR):-0.56

Loading ...

IO Biotech Faces Setback as FDA Opposes Cylembio BLA Submission, Morgan Stanley Says

MT Newswires Live
·
Sep 30

Morgan Stanley Downgrades IO Biotech to Equalweight From Overweight, Cuts Price Target to $0.39 From $4

MT Newswires Live
·
Sep 30

Hold Rating for IO Biotech Amid Regulatory and Financial Challenges

TIPRANKS
·
Sep 30

TD Cowen downgrades IO Biotech (IOBT) to a Hold

TIPRANKS
·
Sep 30

IO Biotech Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Sep 30

BUZZ-IO Biotech drops after FDA recommends another late-stage study for cancer vaccine

Reuters
·
Sep 30

H.C. Wainwright downgrades IO Biotech (IOBT) to a Hold

TIPRANKS
·
Sep 30

H.C. Wainwright downgrades IO Biotech after FDA recommends another Phase 3 trial

TIPRANKS
·
Sep 30

IO Biotech Advised Against Filing Biologics License Application for Cylembio; Plans to Cut 50% of Workforce

MT Newswires Live
·
Sep 29

FDA Recommends Against IO Biotech’s Cylembio Application

TIPRANKS
·
Sep 29

IO Biotech to Reduce Headcount by 50% Amid Restructuring

Dow Jones
·
Sep 29

BRIEF-IO Biotech Provides Update Following Pre-BLA Meeting with FDA

Reuters
·
Sep 29

IO Biotech Inc - to Reduce Workforce by About 50%

THOMSON REUTERS
·
Sep 29

IO Biotech Provides Update Following Pre-Bla Meeting With FDA

THOMSON REUTERS
·
Sep 29

IO Biotech Inc - Expects $1.0 Mln-$1.5 Mln Charge in Q3 2025

THOMSON REUTERS
·
Sep 29

IO Biotech Inc - Plans New Study for Cylembio in Melanoma

THOMSON REUTERS
·
Sep 29

IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025

GlobeNewswire
·
Sep 23

IO Biotech Inc : Jefferies Cuts Target Price to $4 From $8

THOMSON REUTERS
·
Sep 09

IO Biotech Announces Participation in Upcoming Investor Conferences

GlobeNewswire
·
Sep 04

IO Biotech Inc reports results for the quarter ended June 30 - Earnings Summary

Reuters
·
Aug 15